Research and Markets: Pharmaceutical Manufacturers & Developers - Business Ratio Report; Comparing the Financial Performance of the Leading Players in This Industry

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/1d12ba/pharmaceutical_man) has
announced the addition of the "Pharmaceutical Manufacturers & Developers -
Business Ratio Report" report to their offering.

This Business Ratio Report compares the financial performance of the leading
players in this Industry sector, offering a quick and cost-effective competitor
analysis tool for senior management.

Ratios are an invaluable tool for comparing the performance of companies on a
like-for-like basis. Using ratios, the relative profitability, growth or debt
levels, for example, of differently sized companies can be directly measured or
compared with ease. This Business Ratio Report focuses on the performance of key
players in the Pharmaceutical Manufacturers & Developers sector. Having closely
analysed the sector, our editors and analysts have compiled the largest
companies, so you don't have to. A Business Ratio report is, in effect, a
complete financial reference for the sector.

This summary brings you a sample of key details from this invaluable Report. The
Report itself includes many further analyses of the performance of individual
companies and the industry as a whole.

This Business Ratio Report focuses on the leading 115 companies operating as
Pharmaceutical Manufacturers & Developers.

The Report analyses company and industry performance over the three years up to
7th July 2008. During this period, the average Report company experienced a 16.5
percent increase in turnover, with sales rising from £188.5 million in 2005/06
to £219.7 million in the third year of review. Pre-tax profits also followed a
positive trend, gaining 7.5 percent from £31.8 million in the initial year of
analysis to reach £34.2 million in the third year.

Key Topics Covered:

Industry Overview

Company Profiles:

Accounting/Financial Data

Performance Analysis:

Financial ratios grouped according to profitability, efficiency, debt, employee
performance and growth.

League Table Positions:

How the company performs relative to all the others in the sector

Performance League Tables

Some Companies Mentioned:

* 3M Health Care Ltd
* 3VS UK Ltd
* Acambis PLC
* Cambridge Biotechnology Ltd
* Cambridge Laboratories Ltd
* Catalent UK Swindon Zydis Ltd
* Dr. Falk Pharma UK Ltd
* Eli Lilly & Co. Ltd
* Macarthys Laboratories Ltd
* Norgine Ltd
* Norton Healthcare Ltd
* Nova Laboratories Ltd
* NPIL Pharmaceuticals (UK) Ltd
* Organon Laboratories Ltd
* Patheon UK Ltd
* Penn Pharmaceutical Services Ltd
* Pfizer Ltd
* Phytopharm PLC
* Pierre Fabre Ltd
* Piramed Ltd
* Protherics PLC
* Reckitt Benckiser Hlthcre (UK) Ltd
* Rhodia Pharma Solutions Ltd
* Richmond Pharmacology Ltd
* Roche Products Ltd
* Rosemont Pharmaceuticals Ltd
* Sandoz Ltd
* Sanofi-Synthelabo Ltd
* E.C.De Witt & Co., Ltd
* Wrafton Laboratories Ltd
* Xenova Ltd

For more information visit
http://www.researchandmarkets.com/research/1d12ba/pharmaceutical_man

Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716

Copyright Business Wire 2009